BioSpace News Archive

Company On Track to Report Topline Data from the 4 mg and 8 mg Twice-Daily Cohorts in Fourth Quarter of 2018

Glysema, a new supplement from Iconis Bioceuticals. Individual Ingredients Support Blood Sugar Levels through a Multiplex Optimization Formula.

- Application Seeks to Expand VRAYLAR Indication to Include the Treatment of Bipolar Depression

Study enables clinical development in complement-mediated renal disorders

The new approximately 170,000 square foot facility will support more than 1,500 employees, including a state-of-the-art pharmacy facility, enhanced software and data science labs, and office space.

CROP INFRASTRUCTRE CORP. (CSE: CROP) (OTC: CRXPF) announces that its subsidiary Elite Ventures Group LLC has signed a joint venture agreement with The Hempire LLC of Nevada (the “Tenant”) to purchase a 100% interest in an 1,000 acre Esmeralda County agricultural cannabis project tenanted with a suite of cannabis licenses including medical cultivation

Johnson Fistel, LLP, a shareholder rights law firm, is investigating potential claims on behalf of investors of TG Therapeutics, Inc.

EffRx Pharmaceuticals SA is proud to announce that recent data from a standardized clinical database suggest an improved safety and tolerability profile of Binosto®

GB Sciences and Catalent tackle the first-ever formulations of APIs containing up to nine cannabinoids and terpenoids for the treatment of Parkinson’s disease.

G-CON Manufacturing and Pall Corporation are collaborating to bring turnkey continuous bioprocess or viral vector production facility solutions to the industry.